Trials / Completed
CompletedNCT02486289
Pilot Proof of Concept Study of NBMI Treatment of Mercury Intoxication
A Randomized, Placebo-controlled Study to Explore Safety, Dose and Efficacy of NBMI in a Mercury Intoxicated Population
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- EmeraMed · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
A randomized, placebo controlled, double blind proof of concept study of NBMI in treatment of mercury intoxication.
Detailed description
The objectives of this study are to evaluate the efficacy and safety of two doses of NBMI compared to placebo in mercury intoxicated patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Emeramide | Mercury chelator NBMI ((N1,N3-bis(2-mercaptoethyl) isophthalamide) |
| DRUG | Placebo | NBMI Placebo |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2016-01-01
- Completion
- 2016-04-01
- First posted
- 2015-07-01
- Last updated
- 2021-03-08
Locations
1 site across 1 country: Ecuador
Source: ClinicalTrials.gov record NCT02486289. Inclusion in this directory is not an endorsement.